Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Cortisol and corticosterone thin mouse skin and regress hair follicles, while testosterone promotes skin and hair development.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

New effective scar treatments are urgently needed due to the current options' limited success.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Triamcinolone is more effective and safer for treating feline pemphigus foliaceus than prednisone.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

More research is needed to understand and treat morphea effectively.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.